| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |